|
Jeffrey Popma, MD, Joins CRF as Chief Scientific and Strategic Officer
|
|
Symbiosis Wins TCT 2024 Shark Tank Innovation Competition
|
|
First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of Peripheral Artery Disease: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
|
|
Randomized Trial Demonstrates Benefits of Large-bore Mechanical Thrombectomy Over Catheter-directed Thrombolysis for Treatment of Intermediate-risk Pulmonary Embolism
|
|
Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes
|
|
Orbital Atherectomy Prior to Coronary Stent Implantation Does Not Lead to Better Outcomes Compared to Conventional Balloon Angioplasty
|
|
Transcatheter Aortic Valve Replacement in Patients with Systolic Heart Failure and Moderate Aortic Stenosis Shows Limited Benefits
|
|
Early Intervention in Patients with Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis Falls Short of Expected Benefits
|
|
Study Finds Early TAVR Can Be Beneficial for Patients with Asymptomatic Severe Aortic Stenosis
|
|
CRF Announces 2024 SET-10 Rankings
|
